首页 正文

Rapid-acting insulin glulisine: a new tool for postprandial glucose control

{{output}}
Insulin glulisine (Apidra®, Sanofi-Aventis) is a novel, rapid-acting insulin analog that replicates normal mealtime insulin secretion more closely than regular human insulin. Compared with regular human insulin, glulisine has a more rapid onset of action and ... ...